Generation of canine dendritic cells from peripheral blood mononuclear cells
Dendritic cells (DCs) are the most potent antigen-presenting cells that are expected to be therapeutic agents for tumor immunotherapy. In this study, we generated DCs of sufficient number for DC-based immunotherapy from peripheral blood mononuclear cells (PBMC) in dogs. PBMC were cultured in the pre...
Saved in:
Published in | Journal of Veterinary Medical Science Vol. 65; no. 6; pp. 663 - 669 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
JAPANESE SOCIETY OF VETERINARY SCIENCE
01.06.2003
Japan Science and Technology Agency |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Dendritic cells (DCs) are the most potent antigen-presenting cells that are expected to be therapeutic agents for tumor immunotherapy. In this study, we generated DCs of sufficient number for DC-based immunotherapy from peripheral blood mononuclear cells (PBMC) in dogs. PBMC were cultured in the presence of phytohemagglutinin (PHA). On day 6, large adherent cells with dendrite-like projections were seen, and the number of these large cells with projections increased on day 8. These cells were positive for esterase staining. They expressed MHC class II, CD11b, CD8 and weakly CD4 on their surface. They tended to make contact with lymphocytes under culture conditions. We obtained about 2-5 × 106 of DCs from 10 ml of peripheral blood. These DCs phagocytosed HEK-293 cells by overnight co-culturing. These cells generated from PBMC are possible canine DCs and are applicable to clinical trials of DC-based whole tumor cell immunotherapy in dogs. |
---|---|
AbstractList | Dendritic cells (DCs) are the most potent antigen-presenting cells that are expected to be therapeutic agents for tumor immunotherapy. In this study, we generated DCs of sufficient number for DC-based immunotherapy from peripheral blood mononuclear cells (PBMC) in dogs. PBMC were cultured in the presence of phytohemagglutinin (PHA). On day 6, large adherent cells with dendrite-like projections were seen, and the number of these large cells with projections increased on day 8. These cells were positive for esterase staining. They expressed MHC class II, CD11b, CD8 and weakly CD4 on their surface. They tended to make contact with lymphocytes under culture conditions. We obtained about 2-5 x 10 super(6) of DCs from 10 ml of peripheral blood. These DCs phagocytosed HEK-293 cells by overnight co-culturing. These cells generated from PBMC are possible canine DCs and are applicable to clinical trials of DC-based whole tumor cell immunotherapy in dogs. Dendritic cells (DCs) are the most potent antigen-presenting cells that are expected to be therapeutic agents for tumor immunotherapy. In this study, we generated DCs of sufficient number for DC-based immunotherapy from peripheral blood mononuclear cells (PBMC) in dogs. PBMC were cultured in the presence of phytohemagglutinin (PHA). On day 6, large adherent cells with dendrite-like projections were seen, and the number of these large cells with projections increased on day 8. These cells were positive for esterase staining. They expressed MHC class II, CD11b, CD8 and weakly CD4 on their surface. They tended to make contact with lymphocytes under culture conditions. We obtained about 2-5 x 10(6) of DCs from 10 ml of peripheral blood. These DCs phagocytosed HEK-293 cells by overnight co-culturing. These cells generated from PBMC are possible canine DCs and are applicable to clinical trials of DC-based whole tumor cell immunotherapy in dogs. Dendritic cells (DCs) are the most potent antigen-presenting cells that are expected to be therapeutic agents for tumor immunotherapy. In this study, we generated DCs of sufficient number for DC-based immunotherapy from peripheral blood mononuclear cells (PBMC) in dogs. PBMC were cultured in the presence of phytohemagglutinin (PHA). On day 6, large adherent cells with dendrite-like projections were seen, and the number of these large cells with projections increased on day 8. These cells were positive for esterase staining. They expressed MHC class II, CD11b, CD8 and weakly CD4 on their surface. They tended to make contact with lymphocytes under culture conditions. We obtained about 2-5 × 106 of DCs from 10 ml of peripheral blood. These DCs phagocytosed HEK-293 cells by overnight co-culturing. These cells generated from PBMC are possible canine DCs and are applicable to clinical trials of DC-based whole tumor cell immunotherapy in dogs. |
Author | Kudo, T Iwasaki, T Taga, N Momoi, Y Ide, K Yoshida, H. (Gifu Univ. (Japan). Faculty of Agriculture) Yamazoe, K |
Author_xml | – sequence: 1 fullname: Yoshida, H. (Gifu Univ. (Japan). Faculty of Agriculture) – sequence: 2 fullname: Momoi, Y – sequence: 3 fullname: Taga, N – sequence: 4 fullname: Ide, K – sequence: 5 fullname: Yamazoe, K – sequence: 6 fullname: Iwasaki, T – sequence: 7 fullname: Kudo, T |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12867724$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc9rFDEUx4NU7LZ68qwMFHqRWfNrkslNKVotC_Wg5_A2edPOMpOsyUyh_71ZZ2nBi5eXw_vw4eX7PSMnIQYk5C2ja8YN_7h7GPNaNWulxAuyYkLqWkthTsiKGqZqzRt6Ss5y3lHKmVTmFTllvFVac7kim2sMmGDqY6hiVzkIfcDKY_Cpn3pXORyGXHUpjtUeU7-_L_BQbYcYfTXGcsnsBoS0cK_Jyw6GjG-O7zn59fXLz6tv9eb2-vvV503tNKdT3VDHOUiPW2NEi1rR1jEOW-C-6QCocQaEAN1x71tjnGgccMNQeKlBMybOyeXi3af4e8Y82bHPhwsgYJyz1aKRmsn2vyCnSnGlDsaLf8BdnFMon7Alsla1rfir-7BQLsWcE3Z2n_oR0qNl1B66sIcurGps6aLQ74_OeTuif2aP4Rfg0wLs8gR3-ARAKskP-Cw7DiWeVu4eksVQFO8WRQfRwl3qs735wSmVlAqtG_EHLsSm2w |
CitedBy_id | crossref_primary_10_1016_j_vetimm_2010_06_006 crossref_primary_10_1016_j_vetimm_2006_07_002 crossref_primary_10_1016_j_vetimm_2005_08_027 crossref_primary_10_1371_journal_pone_0096121 crossref_primary_10_1016_j_vetimm_2004_08_022 crossref_primary_10_1016_j_jim_2005_02_001 crossref_primary_10_1292_jvms_10_0470 crossref_primary_10_1051_vetres_2010012 crossref_primary_10_1089_1536859041651303 crossref_primary_10_1016_j_vetimm_2012_12_003 crossref_primary_10_1016_j_patbio_2005_04_005 crossref_primary_10_1016_j_cellimm_2010_03_003 crossref_primary_10_1016_j_tvjl_2007_09_021 crossref_primary_10_1016_j_vetimm_2007_05_010 |
Cites_doi | 10.1046/j.1440-1746.2000.02241.x 10.1097/00002371-200109000-00001 10.1089/15258160152509163 10.4049/jimmunol.165.3.1705 10.1200/JCO.2000.18.2.376 10.1159/000030291 10.1097/00007890-199501150-00020 10.1097/00008390-199910000-00007 10.1016/0165-2427(85)90001-7 10.1016/0277-5379(91)90170-I 10.1006/cimm.2001.1760 10.1016/S1471-4914(01)02101-3 10.1007/978-1-4615-1971-3_49 10.4049/jimmunol.161.10.5516 10.1016/S1471-4906(01)02016-6 10.3109/07357908609017520 10.1002/(SICI)1097-0215(19980413)76:2<250::AID-IJC13>3.0.CO;2-G 10.1084/jem.188.7.1359 10.1007/s002620100205 10.1002/ijc.1323 10.1097/00007890-198612000-00015 10.1002/(SICI)1097-0215(19990118)80:2<324::AID-IJC25>3.0.CO;2-D 10.1097/00002371-200101000-00008 10.1016/S0198-8859(99)00030-0 10.1007/s002620050317 10.1002/eji.1830270213 10.4049/jimmunol.160.7.3081 10.1016/S0165-2427(97)00144-X 10.1046/j.1440-1711.1999.00859.x 10.1016/S0195-5616(85)50053-4 10.1053/ctrv.2001.0221 10.1002/1097-0215(200002)9999:9999<::AID-IJC1141>3.0.CO;2-X 10.1177/030098588602300407 10.1097/00007890-200011270-00007 10.1046/j.1365-3024.2001.00374.x 10.1016/S0022-5347(05)65642-X 10.1097/00000372-200002000-00009 |
ContentType | Journal Article |
Copyright | 2003 by the Japanese Society of Veterinary Science Copyright Japan Science and Technology Agency 2003 |
Copyright_xml | – notice: 2003 by the Japanese Society of Veterinary Science – notice: Copyright Japan Science and Technology Agency 2003 |
DBID | FBQ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QR 7U9 8FD FR3 H94 M7N P64 7T5 7X8 |
DOI | 10.1292/jvms.65.663 |
DatabaseName | AGRIS Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Chemoreception Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Technology Research Database Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Veterinary Medicine |
EISSN | 1347-7439 |
EndPage | 669 |
ExternalDocumentID | 3158568841 10_1292_jvms_65_663 12867724 article_jvms_65_6_65_6_663_article_char_en JP2004003775 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 29L 2WC 53G 5GY ACGFO ACIWK ACPRK ADBBV ADRAZ AENEX AFRAH AI. ALMA_UNASSIGNED_HOLDINGS AOIJS B.T BAWUL CS3 DIK DU5 E3Z EBS EJD FBQ HYE JSF JSH KQ8 M48 M~E N5S OK1 P2P RJT RNS RPM RYR RZJ TKC TR2 VH1 XSB CGR CUY CVF ECM EIF NPM PGMZT AAYXX CITATION 7QR 7U9 8FD FR3 H94 M7N P64 7T5 7X8 |
ID | FETCH-LOGICAL-c720t-50c22a4deb9938e7608c12aba2d5faa09c9a33a7f2dd899c35ca291e3d47a7113 |
ISSN | 0916-7250 |
IngestDate | Fri Aug 16 00:53:51 EDT 2024 Fri Apr 12 04:31:31 EDT 2024 Thu Oct 10 20:27:22 EDT 2024 Fri Aug 23 00:41:59 EDT 2024 Sat Sep 28 08:37:40 EDT 2024 Wed Apr 05 11:14:13 EDT 2023 Tue Nov 07 23:22:25 EST 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c720t-50c22a4deb9938e7608c12aba2d5faa09c9a33a7f2dd899c35ca291e3d47a7113 |
Notes | L70 2004003775 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/jvms/65/6/65_6_663/_article/-char/en |
PMID | 12867724 |
PQID | 1468688348 |
PQPubID | 2028964 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_73547148 proquest_miscellaneous_20662661 proquest_journals_1468688348 crossref_primary_10_1292_jvms_65_663 pubmed_primary_12867724 jstage_primary_article_jvms_65_6_65_6_663_article_char_en fao_agris_JP2004003775 |
PublicationCentury | 2000 |
PublicationDate | 2003-06-01 |
PublicationDateYYYYMMDD | 2003-06-01 |
PublicationDate_xml | – month: 06 year: 2003 text: 2003-06-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Tokyo |
PublicationTitle | Journal of Veterinary Medical Science |
PublicationTitleAlternate | J. Vet. Med. Sci. |
PublicationYear | 2003 |
Publisher | JAPANESE SOCIETY OF VETERINARY SCIENCE Japan Science and Technology Agency |
Publisher_xml | – name: JAPANESE SOCIETY OF VETERINARY SCIENCE – name: Japan Science and Technology Agency |
References | 9. Ferguson, H.R. 1985. Canine mammary gland tumors. Vet. Clin. North Am. Small Anim. Pract. 15: 501-511. 40. Thurnher, M., Rieser, C., Holtl, L., Papesh, C., Ramoner, R. and Bartsch, G. 1998. Dendritic cell-based immunotherapy of renal cell carcinoma. Urol. Int. 61: 67-71. 15. Goodell, E.M., Blumenstock, D.A. and Bowers, W.E. 1985. Canine dendritic cells from peripheral blood and lymph nodes. Vet. Immunol. Immunopathol. 8: 301-310. 8. Fallarino, F., Uyttenhove, C., Boon, T. and Gajewski, T.F. 1999. Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12. Int. J. Cancer 80: 324-333. 18. Hoffman, D.M., Gitlitz, B.J., Belldegrun, A. and Figlin, R.A. 2000. Adoptive cellular therapy. Semin. Oncol. 27: 221-233. 16. Hagglund, H.G., McSweeney, P.A., Mathioudakis, G., Bruno, B., Georges, G.E., Gass, M.J., Moore, P., Sale, G.E., Storb, R. and Nash, R.A. 2000. Ex vivo expansion of canine dendritic cells from CD34+ bone marrow progenitor cells. Transplantation 70: 1437-1442. 32. Moore, P.F. 1986. Characterization of cytoplasmic lysozyme immunoreactivity as a histiocytic marker in normal canine tissues. Vet. Pathol. 23: 763-769. 1. Affolter, V.K. and Moore, P.F. 2000. Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells. Am. J. Dermatopathol. 22: 40-48. 3. Aprile, J. and Deeg, H.J. 1986. Ultraviolet irradiation of canine dendritic cells prevents mitogen-induced cluster formation and lymphocyte proliferation. Transplantation 42: 653-660. 17. Hart, D.N. and Hill, G.R. 1999. Dendritic cell immunotherapy for cancer: application to low-grade lymphoma and multiple myeloma. Immunol. Cell Biol. 77: 451-459. 4. Bhardwaj, N. 2001. Processing and presentation of antigens by dendritic cells: implications for vaccines. Trends Mol. Med. 7: 388-394. 25. Lau, R., Wang, F., Jeffery, G., Marty, V., Kuniyoshi, J., Bade, E., Ryback, M.E. and Weber, J. 2001. Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma. J. Immunother. 24: 66-78. 39. Thomas, R., Chambers, M., Boytar, R., Barker, K., Cavanagh, L.L., MacFadyen, S., Smithers, M., Jenkins, M. and Andersen, J. 1999. Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy. Melanoma Res. 9: 474-481. 21. June, C.H. 2001. Can't get any help? New approaches for adoptive immunotherapy of cancer. J. Immunother. 24: 389-391. 37. Smyth, M.J. 2001. Cancer immunotherapy-broader considerations. Trends Immunol. 22: 642. 13. Gluckman, J.C., Canque, B., Chapuis, F. and Rosenzwajg, M. 1997. In vitro generation of human dendritic cells and cell therapy. Cytokines Cell Mol. Ther. 3: 187-196. 22. Kalhs, P., White, J.S., Gervassi, A., Storb, R. and Bean, M.A. 1995. In vitro recall of proliferative and cytolytic responses to minor histocompatibility antigens by dendritic cell enriched canine peripheral blood mononuclear cells. Transplantation 59: 112-118. 36. Sprinzl, G.M., Kacani, L., Schrott-Fischer, A., Romani, N. and Thumfart, W.F. 2001. Dendritic cell vaccines for cancer therapy. Cancer Treat. Rev. 27: 247-255. 35. Shurin, M.R. 1996. Dendritic cells presenting tumor antigen. Cancer Immunol. Immunother. 43: 158-164. 33. Morales, A., Chin, J.L. and Ramsey, E.W. 2001. Mycobacterial cell wall extract for treatment of carcinoma in situ of the bladder. J. Urol. 166: 1633-1638. 19. Jenne, L., Arrighi, J.F., Sauter, B. and Kern, P. 2001. Dendritic cells pulsed with unfractionated helminthic proteins to generate antiparasitic cytotoxic T lymphocyte. Parasite Immunol. 23: 195-201. 38. Steinman, R.M., Inaba, K., Turley, S., Pierre, P. and Mellman, I. 1999. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60: 562-567. 31. Meij, P., Bloemena, E., Palmen, N., Brink, A., Vervoort, M.B., Meijer, C.J. and Middeldorp, J.M. 2001. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines. Cell. Immunol. 208: 25-33. 5. Celluzzi, C.M. and Falo, L.D. Jr. 1998. Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J. Immunol. 160: 3081-3085. 30. Marchal, T., Saint-Andre, I., Magnol, J.P., Dezutter-Dambuyant, C. and Schmitt, D. 1995. Dendritic cells in dogs and cats: models of study in human pathology. Pathol. Biol. (Paris) 43: 910-920. 41. Wang, J., Saffold, S., Cao, X., Krauss, J. and Chen, W. 1998. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J. Immunol. 161: 5516-5524. 29. Marchal, T., Dezutter-Dambuyant, C., Bourdoiseau, G., Magnol, J.P. and Schmitt, D. 1995a. Evidence that Langerhans cells migrate to regional lymph nodes during experimental contact sensitization in dogs. Adv. Exp. Med. Biol. 378: 219-221. 34. Schreurs, M.W., Eggert, A.A., de Boer, A.J., Vissers, J.L., van Hall, T., Offringa, R., Figdor, C.G. and Adema, G.J. 2000. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model. Cancer Res. 60: 6995-7001. 24. Kurokawa, T., Oelke, M. and Mackensen, A. 2001. Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells. Int. J. Cancer 91: 749-756. 26. Lespagnard, L., Mettens, P., Verheyden, A.M., Tasiaux, N., Thielemans, K., van Meirvenne, S., Geldhof, A., De Baetselier, P., Urbain, J., Leo, O. and Moser, M. 1998. Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity. Int. J. Cancer. 76: 250-258. 7. Chen, W., Rains, N., Young, D. and Stubbs, R.S. 2000. Dendritic cell-based cancer immunotherapy: potential for treatment of colorectal cancer? J. Gastroenterol. Hepatol. 15: 698-705. 23. Kikuchi, T., Akasaki, Y., Irie, M., Homma, S., Abe, T. and Ohno, T. 2001. Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol. Immunother. 50: 337-344. 2. Albert, M.L., Pearce, S.F., Francisco, L.M., Sauter, B., Roy P., Silverstein, R.L. and Bhardwaj, N. 1998. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188: 1359-1368. 12. German, A.J., Bland, P.W., Hall, E.J. and Day, M.J. 1998. Expression of major histocompatibility complex class II antigens in the canine intestine. Vet. Immunol. Immunopathol. 61: 171-180. 11. Garderet, L., Cao H., Salamero, J., Verge, V., Tisserand, E., Scholl, S., Gorin, N.C. and Lopez, M. 2001. In vitro production of dendritic cells from human blood monocytes for therapeutic use. J. Hematother. Stem Cell Res. 10: 553-567. 20. Jonuleit, H., Giesecke-Tuettenberg, A., Tuting, T., Thurner-Schuler, B., Stuge, T.B., Paragnik, L., Kandemir, A., Lee, P.P., Schuler, G., Knop, J. and Enk, A.H. 2001. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int. J. Cancer 93: 243-251. 27. Liebrich, W., Schlag, P., Manasterski, M., Lehner, B., Stohr, M., Moller, P. and Schirrmacher, V. 1991. In vitro and clinical characterisation of a Newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patients. Eur. J. Cancer 27: 703-710. 28. MacEwen, E.G., Patnaik, A.K., Harvey, H.J., Hayes, A.A. and Matus, R. 1986. Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum. Cancer Invest. 4: 397-402. 6. Chapuis, F., Rosenzwajg, M., Yagello, M., Ekman, M., Biberfeld, P. and Gluckman, J.C. 1997. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 27: 431-441. 14. Gong, J., Nikrui, N., Chen, D., Koido, S., Wu Z., Tanaka, Y., Cannistra, S., Avigan, D. and Kufe, D. 2000. Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. J. Immunol. 165: 1705-1711. 10. Foon, K.A., Lutzky, J., Baral, R.N., Yannelli, J.R., Hutchins, L., Teitelbaum, A., Kashala, O.L., Das, R., Garrison, J., Reisfeld, R.A. and Bhattacharya-Chatterjee, M. 2000. Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2. J. Clin. Oncol. 18: 376-384. Hoffman, D.M., Gitlitz, B.J., Belldegrun, A. and Figlin, R.A. (18) 2000; 27 WANG J (41) 1998; 161 23 24 25 26 Schreurs, M.W., Eggert, A.A., de Boer, A.J., Vissers, J.L., van Hall, T., Offringa, R., Figdor, C.G. and Adema, G.J. (34) 2000; 60 GONG J (14) 2000; 165 Gluckman, J.C., Canque, B., Chapuis, F. and Rosenzwajg, M. (13) 1997; 3 (5) 1998; 160 FOON K A (10) 2000; 18 Hagglund, H.G., McSweeney, P.A., Mathioudakis, G., Bruno, B., Georges, G.E., Gass, M.J., Moore, P., Sale, G.E., Storb, R. and Nash, R.A. (16) 2000; 70 31 11 12 35 36 Aprile, J. and Deeg, H.J. (3) 1986; 42 15 37 38 (6) 1997; 27 17 19 MacEwen, E.G., Patnaik, A.K., Harvey, H.J., Hayes, A.A. and Matus, R. (28) 1986; 4 Thomas, R., Chambers, M., Boytar, R., Barker, K., Cavanagh, L.L., MacFadyen, S., Smithers, M., Jenkins, M. and Andersen, J. (39) 1999; 9 1 Marchal, T., Saint-Andre, I., Magnol, J.P., Dezutter-Dambuyant, C. and Schmitt, D. (30) 1995; 43 2 Moore, P.F. (32) 1986; 23 4 Ferguson, H.R. (9) 1985; 15 Kalhs, P., White, J.S., Gervassi, A., Storb, R. and Bean, M.A. (22) 1995; 59 Liebrich, W., Schlag, P., Manasterski, M., Lehner, B., Stohr, M., Moller, P. and Schirrmacher, V. (27) 1991; 27 7 8 Morales, A., Chin, J.L. and Ramsey, E.W. (33) 2001; 166 40 20 21 (29) 1995; 378 |
References_xml | – ident: 7 doi: 10.1046/j.1440-1746.2000.02241.x – ident: 21 doi: 10.1097/00002371-200109000-00001 – ident: 11 doi: 10.1089/15258160152509163 – volume: 165 start-page: 1705 issn: 0022-1767 issue: 3 year: 2000 ident: 14 publication-title: J. Immunol. doi: 10.4049/jimmunol.165.3.1705 contributor: fullname: GONG J – volume: 18 start-page: 376 issn: 0732-183X issue: 2 year: 2000 ident: 10 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2000.18.2.376 contributor: fullname: FOON K A – ident: 40 doi: 10.1159/000030291 – volume: 59 start-page: 112 issn: 0041-1337 year: 1995 ident: 22 publication-title: Transplantation doi: 10.1097/00007890-199501150-00020 contributor: fullname: Kalhs, P., White, J.S., Gervassi, A., Storb, R. and Bean, M.A. – volume: 9 start-page: 474 issn: 0960-8931 year: 1999 ident: 39 publication-title: Melanoma Res. doi: 10.1097/00008390-199910000-00007 contributor: fullname: Thomas, R., Chambers, M., Boytar, R., Barker, K., Cavanagh, L.L., MacFadyen, S., Smithers, M., Jenkins, M. and Andersen, J. – ident: 15 doi: 10.1016/0165-2427(85)90001-7 – volume: 60 start-page: 6995 year: 2000 ident: 34 publication-title: Cancer Res. contributor: fullname: Schreurs, M.W., Eggert, A.A., de Boer, A.J., Vissers, J.L., van Hall, T., Offringa, R., Figdor, C.G. and Adema, G.J. – volume: 27 start-page: 221 issn: 0093-7754 year: 2000 ident: 18 publication-title: Semin. Oncol. contributor: fullname: Hoffman, D.M., Gitlitz, B.J., Belldegrun, A. and Figlin, R.A. – volume: 27 start-page: 703 issn: 0014-2964 year: 1991 ident: 27 publication-title: Eur. J. Cancer doi: 10.1016/0277-5379(91)90170-I contributor: fullname: Liebrich, W., Schlag, P., Manasterski, M., Lehner, B., Stohr, M., Moller, P. and Schirrmacher, V. – ident: 31 doi: 10.1006/cimm.2001.1760 – ident: 4 doi: 10.1016/S1471-4914(01)02101-3 – volume: 378 start-page: 219 issn: 0065-2598 year: 1995 ident: 29 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4615-1971-3_49 – volume: 161 start-page: 5516 issn: 0022-1767 issue: 10 year: 1998 ident: 41 publication-title: J. Immunol. doi: 10.4049/jimmunol.161.10.5516 contributor: fullname: WANG J – ident: 37 doi: 10.1016/S1471-4906(01)02016-6 – volume: 4 start-page: 397 issn: 0735-7907 year: 1986 ident: 28 publication-title: Cancer Invest. doi: 10.3109/07357908609017520 contributor: fullname: MacEwen, E.G., Patnaik, A.K., Harvey, H.J., Hayes, A.A. and Matus, R. – ident: 26 doi: 10.1002/(SICI)1097-0215(19980413)76:2<250::AID-IJC13>3.0.CO;2-G – ident: 2 doi: 10.1084/jem.188.7.1359 – ident: 23 doi: 10.1007/s002620100205 – volume: 43 start-page: 910 issn: 0369-8114 year: 1995 ident: 30 publication-title: Pathol. Biol. (Paris) contributor: fullname: Marchal, T., Saint-Andre, I., Magnol, J.P., Dezutter-Dambuyant, C. and Schmitt, D. – ident: 20 doi: 10.1002/ijc.1323 – volume: 42 start-page: 653 issn: 0041-1337 year: 1986 ident: 3 publication-title: Transplantation doi: 10.1097/00007890-198612000-00015 contributor: fullname: Aprile, J. and Deeg, H.J. – ident: 8 doi: 10.1002/(SICI)1097-0215(19990118)80:2<324::AID-IJC25>3.0.CO;2-D – ident: 25 doi: 10.1097/00002371-200101000-00008 – ident: 38 doi: 10.1016/S0198-8859(99)00030-0 – ident: 35 doi: 10.1007/s002620050317 – volume: 27 start-page: 431 issn: 0014-2980 issue: 2 year: 1997 ident: 6 publication-title: Eur. J. Immunol. doi: 10.1002/eji.1830270213 – volume: 160 start-page: 3081 issn: 0022-1767 issue: 7 year: 1998 ident: 5 publication-title: J. Immunol. doi: 10.4049/jimmunol.160.7.3081 – ident: 12 doi: 10.1016/S0165-2427(97)00144-X – ident: 17 doi: 10.1046/j.1440-1711.1999.00859.x – volume: 15 start-page: 501 issn: 0195-5616 year: 1985 ident: 9 publication-title: Vet. Clin. North Am. Small Anim. Pract. doi: 10.1016/S0195-5616(85)50053-4 contributor: fullname: Ferguson, H.R. – ident: 36 doi: 10.1053/ctrv.2001.0221 – volume: 3 start-page: 187 issn: 1368-4736 year: 1997 ident: 13 publication-title: Cytokines Cell Mol. Ther. contributor: fullname: Gluckman, J.C., Canque, B., Chapuis, F. and Rosenzwajg, M. – ident: 24 doi: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1141>3.0.CO;2-X – volume: 23 start-page: 763 issn: 0300-9858 year: 1986 ident: 32 publication-title: Vet. Pathol. doi: 10.1177/030098588602300407 contributor: fullname: Moore, P.F. – volume: 70 start-page: 1437 issn: 0041-1337 year: 2000 ident: 16 publication-title: Transplantation doi: 10.1097/00007890-200011270-00007 contributor: fullname: Hagglund, H.G., McSweeney, P.A., Mathioudakis, G., Bruno, B., Georges, G.E., Gass, M.J., Moore, P., Sale, G.E., Storb, R. and Nash, R.A. – ident: 19 doi: 10.1046/j.1365-3024.2001.00374.x – volume: 166 start-page: 1633 issn: 0022-5347 year: 2001 ident: 33 publication-title: J. Urol. doi: 10.1016/S0022-5347(05)65642-X contributor: fullname: Morales, A., Chin, J.L. and Ramsey, E.W. – ident: 1 doi: 10.1097/00000372-200002000-00009 |
SSID | ssj0021469 |
Score | 1.7430618 |
Snippet | Dendritic cells (DCs) are the most potent antigen-presenting cells that are expected to be therapeutic agents for tumor immunotherapy. In this study, we... |
SourceID | proquest crossref pubmed jstage fao |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 663 |
SubjectTerms | Animals Antigens, CD - analysis BLOOD CELLS canine Cell Differentiation - drug effects Cell Line Cells, Cultured Coculture Techniques Cricetinae Culture Media - chemistry dendritic cell Dendritic Cells - cytology Dendritic Cells - drug effects Dendritic Cells - immunology Dendritic Cells - metabolism DOGS Esterases - metabolism Flow Cytometry Humans IMMUNOTHERAPY LECTINS Leukocytes, Mononuclear - cytology Leukocytes, Mononuclear - drug effects PBMC Phagocytosis phytohemagglutinin Phytohemagglutinins - pharmacology |
Title | Generation of canine dendritic cells from peripheral blood mononuclear cells |
URI | https://www.jstage.jst.go.jp/article/jvms/65/6/65_6_663/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/12867724 https://www.proquest.com/docview/1468688348 https://search.proquest.com/docview/20662661 https://search.proquest.com/docview/73547148 |
Volume | 65 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Veterinary Medical Science, 2003, Vol.65(6), pp.663-669 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nj9JAFJ_gevFidHUVXbWHvRGQzkenPSKwwgrLJoLh1kzbYcMuSw2lm-h_4n_rmw_aEsWol4Z0ph363m_ex8x7bxA6AwgIVXYdLDcqmjTWQQA8Ai-lzQPP9wjVu-fjS28woxdzNq_VflSilvJt1Iq__zav5H-4CveArypL9h84W7wUbsBv4C9cgcNw_Ssem5rRO5uvK9bKZOzJdaLPL2h05WqVmQSSK_g7uoDAqvFBhaqruZyuVS1jsTH9Dlip9ypcxuTs3tk9Has0C3kx-TwY9jpahy036W1a8HAyngy1iBdZ_i2_XRarBJ2PHSPZt1le9h_2-ia-I90s9xYjSBk0ZRQFKPhSKqmV_3KDoNHRyaTVFUgXIIJN3dmWNPKXUN5UPlJVQJvDJCwQq9LWM7LxFy2AA1VV9ub-Lmt5rGV77dfavpyE57PRKJz259P9VqPbXXCjPN9XJREeYh4wFS3aG34qfHlQMKaMo_0Gm_oJI7-vjLtn7DxYiBTsnBuw-q_lYYdGGzbTJ-ix5bXTMfB6impyfYyOvxR8d8Y2_OIZGpWAc9KFYwDnFIBzNJAcBTinBJyjAedUAGf6PUez8_60O2ja4ziaMcftbZO1Y4wFTWQENq0vudf2YxeLSOCELYRoB3EgCBF8gZMEvPiYsFjgwJUkoVxw1yUn6AhGki-RE1POmEyI9KWkJJK-JzGoO8ki6UYU0zo629Et_GqqroTKWwXyhoq8ocdCIG8dnQBNQ3EN-jC8uMJaIxHOWR0FhszF03aOlk_bi0eKJpXmCFKljk53nAntXM-Ug-wDHAj16-hd0QySWG2vibVM8yxUByMoc_dwD04Y2ILqHS8Mx8uPw6quJKav_jz4a_SonHWn6Gi7yeUbMIq30VsNz59lO7gx |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Generation+of+Canine+Dendritic+Cells+from+Peripheral+Blood+Mononuclear+Cells&rft.jtitle=Journal+of+veterinary+medical+science&rft.au=YOSHIDA%2C+Hiroko&rft.au=MOMOI%2C+Yasuyuki&rft.au=TAGA%2C+Natsuko&rft.au=IDE%2C+Kaori&rft.date=2003-06-01&rft.pub=Japan+Science+and+Technology+Agency&rft.issn=0916-7250&rft.eissn=1347-7439&rft.volume=65&rft.issue=6&rft.spage=663&rft_id=info:doi/10.1292%2Fjvms.65.663&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3158568841 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-7250&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-7250&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-7250&client=summon |